TCM Ltd.
BSE: TCMLMTD · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock TCM Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
TCM Limited is an Indian company that has transitioned from its historical roots in copper-based chemical manufacturing to a diversified portfolio. The firm currently operates across renewable energy, healthcare equipment distribution, and education technology sectors.
Business Model
The company generates revenue through the execution of solar power projects, the distribution of medical and diagnostic equipment, and the provision of technology-driven educational services.
Management Commentary
Management is focused on pivoting the company's legacy industrial presence toward modern, high-growth technology and sustainability sectors.
Growth Outlook
Future growth is expected to be driven by the expansion of its green energy division and the scaling of its healthcare and ed-tech service offerings.
Key Risks
- Execution Risk. The company faces challenges in successfully integrating and scaling operations across highly diverse and unrelated business segments.
- Market Volatility. As a small-cap entity, the company is susceptible to significant stock price fluctuations and liquidity constraints on the Bombay Stock Exchange.
- Regulatory Risk. Changes in government policies regarding renewable energy subsidies and healthcare equipment import regulations could adversely impact profitability.
- Competitive Pressure. The company must compete with established players in the healthcare and education technology sectors, which may pressure margins.
Start your research today
Unlock AI insights, financials, peers and live data on TCM Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹20 Cr
TTM · consolidated
NET PROFIT
₹6 Cr
TTM · consolidated
EPS
₹7.78
TTM · consolidated
RETURN ON EQUITY
20.6%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
26.3%
TTM · consolidated
P/E
5.5x
Q4 FY26 · consolidated
EV/EBITDA
6.0x
Q4 FY26 · consolidated
EBITDA MARGIN
43.2%
TTM · consolidated
NET PROFIT MARGIN
33.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.9x
Q4 FY26 · consolidated
Peers · Commodity Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
TCM Ltd.TCMLMTD | ₹31 Cr | 5.34 | 6.19 | -24.1% | 43.2% | 20.6% | 26.3% | +4.6% |
Blue Pearl Agriventures LimitedBPAGRI | ₹525 Cr | — | — | — | 2.7% | — | — | -92.2% |
Primo ChemicalsPRIMO | ₹517 Cr | 32.82 | 7.31 | -2.7% | 15.8% | 4.0% | 7.1% | -16.6% |
POCL EnterprisesPOEL | ₹460 Cr | 10.53 | 7.57 | — | 5.3% | 21.3% | 33.7% | -37.2% |
Mangalam OrganicMANORG | ₹437 Cr | 21.41 | 8.88 | 17.3% | 13.6% | 6.8% | 15.9% | -7.2% |
Lords Chloro Alkali LimitedLORDSCHLO | ₹402 Cr | 11.52 | 7.91 | 29.8% | 17.3% | 15.6% | 14.1% | -18.7% |
As of Q4 FY26
Financials
TCM Ltd.
BSE: TCMLMTD · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock TCM Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
TCM Limited is an Indian company that has transitioned from its historical roots in copper-based chemical manufacturing to a diversified portfolio. The firm currently operates across renewable energy, healthcare equipment distribution, and education technology sectors.
Business Model
The company generates revenue through the execution of solar power projects, the distribution of medical and diagnostic equipment, and the provision of technology-driven educational services.
Management Commentary
Management is focused on pivoting the company's legacy industrial presence toward modern, high-growth technology and sustainability sectors.
Growth Outlook
Future growth is expected to be driven by the expansion of its green energy division and the scaling of its healthcare and ed-tech service offerings.
Key Risks
- Execution Risk. The company faces challenges in successfully integrating and scaling operations across highly diverse and unrelated business segments.
- Market Volatility. As a small-cap entity, the company is susceptible to significant stock price fluctuations and liquidity constraints on the Bombay Stock Exchange.
- Regulatory Risk. Changes in government policies regarding renewable energy subsidies and healthcare equipment import regulations could adversely impact profitability.
- Competitive Pressure. The company must compete with established players in the healthcare and education technology sectors, which may pressure margins.
Start your research today
Unlock AI insights, financials, peers and live data on TCM Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹20 Cr
TTM · consolidated
NET PROFIT
₹6 Cr
TTM · consolidated
EPS
₹7.78
TTM · consolidated
RETURN ON EQUITY
20.6%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
26.3%
TTM · consolidated
P/E
5.5x
Q4 FY26 · consolidated
EV/EBITDA
6.0x
Q4 FY26 · consolidated
EBITDA MARGIN
43.2%
TTM · consolidated
NET PROFIT MARGIN
33.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.9x
Q4 FY26 · consolidated
Peers · Commodity Chemicals
As of Q4 FY26